Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 29, 2026

9 minutes ago

Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results

GlobeNewswire

11 minutes ago

Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution

GlobeNewswire

11 minutes ago

OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May

GlobeNewswire

11 minutes ago

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

GlobeNewswire

11 minutes ago

EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026

GlobeNewswire

11 minutes ago

VitalHub Announces Q1 2026 Conference Call Date

GlobeNewswire

11 minutes ago

Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)

GlobeNewswire

11 minutes ago

Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD

GlobeNewswire

11 minutes ago

Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium…

GlobeNewswire

11 minutes ago

Amarin Reports 2026 First Quarter Financial Results

GlobeNewswire

11 minutes ago

Intellia Therapeutics Announces Pricing of Public Offering of Common Stock

GlobeNewswire

17 minutes ago

Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives

GlobeNewswire

41 minutes ago

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

GlobeNewswire

41 minutes ago

Regeneron Reports First Quarter 2026 Financial and Operating Results

GlobeNewswire

41 minutes ago

Agios Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire

an hour ago

Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs

GlobeNewswire

an hour ago

Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference

GlobeNewswire

an hour ago

HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

GlobeNewswire

4 hours ago

EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome

GlobeNewswire

4 hours ago

Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers

GlobeNewswire